Skip to main content

Peer Review reports

From: Dual targeting of MEK and PI3K effectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with different genetic backgrounds

Original Submission
14 Apr 2021 Submitted Original manuscript
11 May 2021 Reviewed Reviewer Report
21 May 2021 Reviewed Reviewer Report
15 Jun 2021 Author responded Author comments - Zhi-Jian Zhang
Resubmission - Version 2
15 Jun 2021 Submitted Manuscript version 2
18 Jun 2021 Author responded Author comments - Zhi-Jian Zhang
Resubmission - Version 3
18 Jun 2021 Submitted Manuscript version 3
19 Jun 2021 Reviewed Reviewer Report
19 Jun 2021 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
21 Jun 2021 Editorially accepted
1 Jul 2021 Article published 10.1186/s12890-021-01571-x

You can find further information about peer review here.

Back to article page